Search Saint Luke's

A gift of $1,000 to Anderson County EMS allowed the department to not only replace but upgrade several emergency response bags.

Individuals enrolled in an accredited nursing program and nurses who want to further their education are eligible to apply for the scholarship, which was established in 1981.

Private gifts to Anderson County Hospital Foundation enhance our facilities, medical programs and the communities we serve.

Dr. Mathis is accepting new patients of all ages and has special interests in pediatrics, women’s health, in-office procedures, and sports medicine.

On the day after Andrew Widman returned home from Saint Luke’s Hospital of Kansas City with his new heart, his wife, Vicki, drove him to the DMV. There he ordered a personalized license plate that read simply “745.” It’s a number that’s particularly close to his heart.

Colorectal Cancer 
M24-533: A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations with ABBV-400 in Subjects with Metastatic Colorectal Cancer– Feasibility Request

An elementary school music teacher and jazz musician, 54-year-old Lisa was initially diagnosed with high blood pressure—the number one killer of women—in her early 30s. It is often called “the silent killer” because most who have it don’t experience any symptoms. Lisa was on blood pressure medication but had stopped taking it because she experienced side effects. She put off seeing her doctor about it for several months.

Ramon Grado doesn’t remember driving home and then sprawling on the living room floor on Jan. 13, 2013. Patty, his wife of 33 years, found him there an hour later, awake and complaining about his headache.

Saint Luke’s Health System Antimicrobial and Diagnostic Advisement Program (ADAP) aims to promote the judicious use of antimicrobials, suppress antimicrobial resistance, decrease the negative effects of unnecessary antimicrobial use, and improve outcomes for the patients we serve.

Pancreatic Cancer

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation